2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA The FDA's Decision to Ban Compounds: What You Need to Know The peptide regulatory landscape in 2026 is in active flux. After the FDA placed 19 popular peptides in Category 2 in late 2023, HHS Secretary RFK Jr. announced in February 2026 that Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org Tesamorelin vs CJC 1295 Ipamorelin: Which Growth Hormone Peptide Is Right for You? Perfect B The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York